Trends in obesity-related cardiovascular and cancer mortality in Switzerland 1995-2019: an analysis of multiple causes of death - Scorecard - MDSpire

Trends in obesity-related cardiovascular and cancer mortality in Switzerland 1995-2019: an analysis of multiple causes of death

  • By

  • Bernadette W A van der Linden

  • Célia A Viehl

  • Nazihah Noor

  • Tim Adair

  • Salvatore Vaccarella

  • Cristian Carmeli

  • January 8, 2026

  • 0 min

Share

Clinical Scorecard: Changes in Obesity-Associated Cardiovascular and Cancer Mortality in Switzerland from 1995 to 2019: A Comprehensive Review of Multiple Death Causes

At a Glance

CategoryDetail
ConditionObesity-associated cardiovascular disease (CVD) and cancer mortality
Key MechanismsObesity increases risk of CVD and cancer mortality through related conditions including diabetes, chronic kidney disease, dyslipidemias, hypertensive heart disease
Target PopulationAdults aged 20 years and older residing in Switzerland
Care SettingPopulation-level public health surveillance and mortality data analysis

Key Highlights

  • Obesity-related CVD and cancer mortality increased from 1995 to 2005 then decreased, while obesity-unrelated mortality rates declined steadily from 1995 to 2019 in Switzerland.
  • Overall CVD mortality declined steadily without slowing due to obesity-related mortality trends, unlike patterns observed in the United States.
  • Younger generations in Switzerland showed lower obesity-related mortality rates, likely due to stable childhood obesity prevalence and improved management of obesity-related conditions.

Guideline-Based Recommendations

Diagnosis

  • Use multiple cause of death (MCOD) data to identify obesity-related mortality by detecting mentions of diabetes, chronic kidney disease, obesity, dyslipidemias, or hypertensive heart disease on death certificates.

Management

  • Focus on prevention and management of obesity and related conditions to reduce CVD and cancer mortality.
  • Maintain efforts to control childhood obesity prevalence to sustain lower obesity-related mortality in younger cohorts.

Monitoring & Follow-up

  • Conduct ongoing surveillance of obesity prevalence and obesity-related mortality trends using national mortality statistics and MCOD approaches.
  • Apply age-period-cohort modeling to assess generational variations in obesity-related mortality.

Risks

  • Obesity significantly increases risk of mortality from cardiovascular diseases and cancers.
  • Rising obesity prevalence can slow declines in overall CVD mortality, as observed in countries with rapid obesity increases.

Patient & Prescribing Data

Adults aged 20 years and older in Switzerland

Improved management of obesity-related conditions contributes to declining obesity-related mortality; stable childhood obesity prevalence supports lower risk in younger generations.

Clinical Best Practices

  • Utilize comprehensive death certificate data including underlying and contributing causes to accurately identify obesity-related mortality.
  • Implement public health strategies targeting obesity prevention and control to reduce associated CVD and cancer deaths.
  • Monitor trends in obesity-related mortality across age cohorts to inform targeted interventions.

References

Original Source(s)

Related Content